Director’s Messages from 2022

In this Director’s message, Dr. Gordon introduces the Somatic Mosaicism across Human Tissues (SMaHT) Network—an NIH-wide initiative that aims to transform our understanding of how somatic mosaicism in human cells influences biology and disease.

In this Director’s message, Dr. Gordon discusses what we have learned about suicide risk and prevention during the COVID-19 pandemic and how NIMH has been building upon these findings to meet the needs of a rapidly changing world.

In this jointly written Director’s Message, Dr. Gordon and Dr. Goodenow discuss the importance of addressing intersectional stigma in the context of HIV prevention, treatment, and care.

In this Director’s Message, Dr. Gordon highlights research supported by the NIMH Small Business Innovation Research program that could advance the development of clinically relevant biomarkers.

In this Director’s Message, Dr. Gordon highlights the increased health risks associated with COVID-19 for people with serious mental illness.

In this message for Autism Awareness Month, Dr. Gordon highlights the importance of a research portfolio that addresses the full spectrum of needs of individuals with autism, across the full lifespan.

In this Director’s message, Dr. Gordon takes a look at NIMH’s portfolio balance, to see where we have come from and where we are headed.

In this Director’s Message, Dr. Gordon provides an update on efforts to advance equity, promote anti-racist ideas and actions, and encourage lasting change at NIMH.